A pioneering cosmetic physician uses Dysport to diminish moderate to severe facial creases; skin makeover includes peels and dermaplaning
What You'll Get
$166 for up to 75 units of Dysport and a full-face evaluation by Dr. Nettles ($350 value)
Typical treatment area for Dysport injections: frown lines between the eyebrows
- Initial digital skin analysis and follow-up analysis after 90 days
- Two chemical peels
- Two deep-exfoliation facials with DermaPlaning
- Brightening and tightening treatments
- Prescription containing ingredients such as vitamin A, retonoic, or bleaching cream with kojic acid
Dysport may cause serious side effects that can be life threatening, including problems swallowing, speaking, or breathing. Read all safety considerations for Dysport here.
The Fine Print
Promotional value expires 120 days after purchase. Amount paid never expires. Dysport can be used on only one area. Must book consultation before expiration. Appointment required. Consultation required; non-candidates and other refund requests will be honored before service provided. Limit 1 per person, may buy 1 additional as gift(s). New customers only. Valid only for option purchased. Merchant is solely responsible to purchasers for the care and quality of the advertised goods and services.
About Dr. Robert Nettles
In his career as a Beverly Hills cosmetic physician, Dr. Robert Nettles weaves together his medical, artistic, and inventive talents to bring his patients solutions for their cosmetic issues. His innovations in cosmetic derma surgery include nonsurgical rhinoplasty that offers nose reshaping without costly hospital stays or fad nose diets. Adopting an empathetic demeanor, the renowned doctor allays patient concerns during pretreatment consultations that match each person's beauty goals with the right treatment. Nettles Non-Surgical Beauty—as well as the doctor's numerous contributions to the field of medical cosmetics—has also been praised on an array of major media outlets that include the Bravo and Fox networks and the Los Angeles Times.